MiR-21 Suppresses Anoikis through Targeting PDCD4 and PTEN in Human Esophageal Adenocarcinoma

Summary Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this stud...

Full description

Saved in:
Bibliographic Details
Published inCurrent medical science Vol. 38; no. 2; pp. 245 - 251
Main Authors Zhao, Meng-ya, Wang, La-mei, Liu, Jing, Huang, Xing, Zhang, Ya-fei
Format Journal Article
LanguageEnglish
Published Wuhan Huazhong University of Science and Technology 01.04.2018
Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430060, China%Department of Emergency Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China%Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Summary Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this study, we revealed that up-regulation of miR-21 in human esophageal adenocarcinoma (EA) is associated with lymph node metastasis and poor survival rate. Because of the established anti-apoptosis effect of miR-21, it is tempting to speculate that miR-21 might contribute to tumor metastasis by regulating anoikis. qRT-PCR analysis demonstrated that miR-21 expression in OE33/AR cells (subpopulation of human EA OE33 cells that acquired resistance to anoikis) was significantly increased. Also, transfection of miR-21 mimics provided OE33 cells resisting to anoikis. By luciferase assays, we verified that PDCD4 and PTEN were the functional targets of miR-21. In mouse model, via tail vein injection experiment, we showed that the metastasis formation of OE33 cells in vivo could be mediated by changing the miR-21 expression pattern. Taken together, our findings suggested that miR-21 was involved in the regulation of anoikis in human EA cells. Targeting miR-21 may provide a novel strategy to prevent metastasis.
AbstractList Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this study, we revealed that up-regulation of miR-21 in human esophageal adenocarcinoma (EA) is associated with lymph node metastasis and poor survival rate. Because of the established anti-apoptosis effect of miR-21, it is tempting to speculate that miR-21 might contribute to tumor metastasis by regulating anoikis. qRT-PCR analysis demonstrated that miR-21 expression in OE33/AR cells (subpopulation of human EA OE33 cells that acquired resistance to anoikis) was significantly increased. Also, transfection of miR-21 mimics provided OE33 cells resisting to anoikis. By luciferase assays, we verified that PDCD4 and PTEN were the functional targets of miR-21. In mouse model, via tail vein injection experiment, we showed that the metastasis formation of OE33 cells in vivo could be mediated by changing the miR-21 expression pattern. Taken together, our findings suggested that miR-21 was involved in the regulation of anoikis in human EA cells. Targeting miR-21 may provide a novel strategy to prevent metastasis.Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this study, we revealed that up-regulation of miR-21 in human esophageal adenocarcinoma (EA) is associated with lymph node metastasis and poor survival rate. Because of the established anti-apoptosis effect of miR-21, it is tempting to speculate that miR-21 might contribute to tumor metastasis by regulating anoikis. qRT-PCR analysis demonstrated that miR-21 expression in OE33/AR cells (subpopulation of human EA OE33 cells that acquired resistance to anoikis) was significantly increased. Also, transfection of miR-21 mimics provided OE33 cells resisting to anoikis. By luciferase assays, we verified that PDCD4 and PTEN were the functional targets of miR-21. In mouse model, via tail vein injection experiment, we showed that the metastasis formation of OE33 cells in vivo could be mediated by changing the miR-21 expression pattern. Taken together, our findings suggested that miR-21 was involved in the regulation of anoikis in human EA cells. Targeting miR-21 may provide a novel strategy to prevent metastasis.
Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this study, we revealed that up-regulation of miR-21 in human esophageal adenocarcinoma (EA) is associated with lymph node metastasis and poor survival rate. Because of the established anti-apoptosis effect of miR-21, it is tempting to speculate that miR-21 might contribute to tumor metastasis by regulating anoikis. qRT-PCR analysis demonstrated that miR-21 expression in OE33/AR cells (subpopulation of human EA OE33 cells that acquired resistance to anoikis) was significantly increased. Also, transfection of miR-21 mimics provided OE33 cells resisting to anoikis. By luciferase assays, we verified that PDCD4 and PTEN were the functional targets of miR-21. In mouse model, via tail vein injection experiment, we showed that the metastasis formation of OE33 cells in vivo could be mediated by changing the miR-21 expression pattern. Taken together, our findings suggested that miR-21 was involved in the regulation of anoikis in human EA cells. Targeting miR-21 may provide a novel strategy to prevent metastasis.
Summary Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a critical step for tumor cell metastasis. MiR-21, the most prominent oncomiR, plays an important role in tumor progression. In this study, we revealed that up-regulation of miR-21 in human esophageal adenocarcinoma (EA) is associated with lymph node metastasis and poor survival rate. Because of the established anti-apoptosis effect of miR-21, it is tempting to speculate that miR-21 might contribute to tumor metastasis by regulating anoikis. qRT-PCR analysis demonstrated that miR-21 expression in OE33/AR cells (subpopulation of human EA OE33 cells that acquired resistance to anoikis) was significantly increased. Also, transfection of miR-21 mimics provided OE33 cells resisting to anoikis. By luciferase assays, we verified that PDCD4 and PTEN were the functional targets of miR-21. In mouse model, via tail vein injection experiment, we showed that the metastasis formation of OE33 cells in vivo could be mediated by changing the miR-21 expression pattern. Taken together, our findings suggested that miR-21 was involved in the regulation of anoikis in human EA cells. Targeting miR-21 may provide a novel strategy to prevent metastasis.
Author Liu, Jing
Zhang, Ya-fei
Wang, La-mei
Zhao, Meng-ya
Huang, Xing
AuthorAffiliation Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430060, China%Department of Emergency Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China%Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
AuthorAffiliation_xml – name: Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430060, China%Department of Emergency Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China%Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
Author_xml – sequence: 1
  givenname: Meng-ya
  surname: Zhao
  fullname: Zhao, Meng-ya
  organization: Tongji Medical College, Huazhong University of Science and Technology
– sequence: 2
  givenname: La-mei
  surname: Wang
  fullname: Wang, La-mei
  organization: Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine
– sequence: 3
  givenname: Jing
  surname: Liu
  fullname: Liu, Jing
  organization: Department of Emergency Medicine, Zhongnan Hospital of Wuhan University
– sequence: 4
  givenname: Xing
  surname: Huang
  fullname: Huang, Xing
  organization: Department of Gastroenterology, Zhongnan Hospital of Wuhan University
– sequence: 5
  givenname: Jing
  surname: Liu
  fullname: Liu, Jing
  organization: Department of Gastroenterology, Zhongnan Hospital of Wuhan University
– sequence: 6
  givenname: Ya-fei
  surname: Zhang
  fullname: Zhang, Ya-fei
  email: zhangyafei1127@163.com
  organization: Department of Gastroenterology, Zhongnan Hospital of Wuhan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30074182$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9v1DAQxS1UREvpB-CCfERCgbGdP85xtV0oUoEKFokLshxnNus2sVM7Ee23x6u0QkKCk8fy743nzXtOjpx3SMhLBm8ZQPUuMlbUZQZMZkxWPKuekBNecJHJuv5xlGpIr-kOx-QsRtuAYLwUTPJn5FikBnkqT8jPT_Zrxhn9No9jwBgx0pXz9sZGOu2Dn7s93erQ4WRdR6_O1-c51a6lV9vNZ2odvZgH7egm-nGvO9Q9XbXovNHBWOcH_YI83ek-4tnDeUq-v99s1xfZ5ZcPH9ery8wICVPWMGiThdJwwFxwjbWQRdkUtSlka0xT4g54JYVpDhZqWdWC5cC0rhHKvGnEKXmz9P2l3U67Tl37Obj0o5qu72_au7tGIU-bAp6MJ_r1Qo_B384YJzXYaLDvtUM_R8VBigqkBJHQVw_o3AzYqjHYQYd79bjABFQLYIKPMeBOGTvpyXo3BW17xUAd0lJLWirNoA5pqcMU7C_lY_P_afiiiYl1HYY_Rv8t-g1apKO1
CitedBy_id crossref_primary_10_1007_s11010_022_04384_6
crossref_primary_10_3389_fonc_2019_00919
crossref_primary_10_1186_s12935_019_0728_y
crossref_primary_10_3892_ijo_2020_4992
crossref_primary_10_3390_ijms22020627
crossref_primary_10_3892_mmr_2019_10138
crossref_primary_10_3389_fonc_2021_702258
crossref_primary_10_3390_nano11123458
crossref_primary_10_3390_pharmaceutics15082061
crossref_primary_10_3390_jcm10010117
crossref_primary_10_1016_j_fct_2018_10_059
crossref_primary_10_1007_s40520_024_02711_z
crossref_primary_10_1016_j_lfs_2021_119926
crossref_primary_10_3892_ijmm_2019_4258
crossref_primary_10_1016_j_tice_2022_101771
crossref_primary_10_1080_15592294_2021_1916697
crossref_primary_10_1080_14737159_2019_1563485
crossref_primary_10_1016_j_cca_2025_120242
crossref_primary_10_1016_j_drup_2024_101099
crossref_primary_10_3390_cancers12010056
crossref_primary_10_1002_ar_24362
crossref_primary_10_1007_s11596_022_2536_1
crossref_primary_10_1016_j_heliyon_2024_e36989
Cites_doi 10.1016/j.bbamcr.2013.06.026
10.1002/ddr.21257
10.1155/2015/716816
10.1016/S1470-2045(12)70073-6
10.1016/j.abb.2015.07.001
10.1158/1078-0432.CCR-12-1959
10.1016/j.canlet.2012.01.003
10.1016/j.jtcvs.2007.08.055
10.1038/mt.2013.35
10.1038/nature08268
10.4161/cbt.10.12.14252
10.1007/s13277-014-1623-8
10.1007/s11596-014-1257-5
10.1124/mi.10.2.5
10.1371/journal.pone.0156772
10.1038/nrg3074
10.1186/1471-2407-14-819
10.1006/meth.2001.1262
10.1159/000454696
10.1038/nrc3767
10.1177/1010428317705754
10.1177/1010428317707372
10.1002/ar.22769
10.3109/0284186X.2015.1064161
10.1590/1414-431X20143906
10.1371/journal.pone.0103373
10.1186/bcr2803
10.18632/oncotarget.4814
10.1155/2013/756134
ContentType Journal Article
Copyright Huazhong University of Science and Technology 2018
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Huazhong University of Science and Technology 2018
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID AAYXX
CITATION
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1007/s11596-018-1872-7
DatabaseName CrossRef
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2523-899X
EndPage 251
ExternalDocumentID tjykdxxb_e201802007
30074182
10_1007_s11596_018_1872_7
Genre Journal Article
GrantInformation_xml – fundername: grants from the National Natural Science Foundation of China
  funderid: (81470818,81472735 and 81472033)
GroupedDBID -05
-0E
-EM
-SE
-S~
.VR
0R~
2J2
2JN
2JY
2KG
2LR
30V
406
408
5VR
92M
95-
96X
9D9
9DE
AAAVM
AACDK
AAHNG
AAIAL
AAJBT
AANZL
AASML
AATNV
AAUYE
AAXDM
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABJNI
ABKCH
ABKZE
ABMQK
ABNWP
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACDTI
ACHSB
ACMDZ
ACMLO
ACOKC
ACZOJ
ADKNI
ADRFC
ADTPH
ADURQ
ADYFF
AEFQL
AEJRE
AEMSY
AESKC
AEVLU
AEXYK
AFBBN
AFLOW
AFQWF
AFUIB
AGDGC
AGJBK
AGMZJ
AGQEE
AGRTI
AHSBF
AIAKS
AIGIU
AILAN
AITGF
AJRNO
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
AXYYD
B-.
BA0
BDATZ
BGNMA
CAJEE
CSCUP
DDRTE
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FSGXE
G-Y
G-Z
GGCAI
GNWQR
GQ7
GRRUI
IKXTQ
IWAJR
IXD
I~Z
J-C
JZLTJ
KOV
LLZTM
M4Y
MA-
NPVJJ
NQJWS
NU0
O9J
PF0
PT4
Q--
QOR
QOS
RHV
ROL
RSV
RT5
S16
S37
S3B
SAP
SCLPG
SDE
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SRMVM
SSLCW
STPWE
SZN
T8U
TCJ
TGQ
TSG
TUC
U1F
U1G
U2A
U5E
U5O
UOJIU
UTJUX
UZXMN
VC2
VFIZW
YLTOR
Z87
ZMTXR
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
NPM
7X8
ABRTQ
-Y2
.86
06C
06D
0VY
1N0
29K
29~
2B.
2KM
2~H
4.4
40D
40E
4A8
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
93N
95.
95~
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABJOX
ABMNI
ABQBU
ABQSL
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADHKG
ADKPE
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AFWTZ
AFZKB
AGAYW
AGQMX
AGQPQ
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
ALWAN
ARMRJ
AZFZN
CAG
CCEZO
CHBEP
CIEJG
COF
CS3
CW9
D-I
ESBYG
FA0
FEDTE
FRRFC
FWDCC
GGRSB
GJIRD
H13
HF~
HMJXF
HRMNR
HVGLF
HZ~
IJ-
I~X
JBSCW
JUIAU
N2Q
NDZJH
O9-
O93
O9I
P9S
PSX
R-E
R89
R9I
RIG
RPX
S..
S1Z
S27
SCL
SMD
SPISZ
SZ9
T13
TT1
U9L
UG4
W48
WK8
ZOVNA
ID FETCH-LOGICAL-c380t-b10d8726c20e432ae93856b59c58dccb6ef02783cb1263987931401aa9e064bb3
IEDL.DBID U2A
ISSN 2096-5230
2523-899X
1672-0733
IngestDate Thu May 29 04:06:48 EDT 2025
Fri Jul 11 10:54:20 EDT 2025
Wed Feb 19 02:42:16 EST 2025
Thu Jul 10 07:35:44 EDT 2025
Thu Apr 24 23:04:10 EDT 2025
Fri Feb 21 02:37:17 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords PDCD4
PTEN
miR-21
esophageal adenocarcinoma
anoikis resistance
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c380t-b10d8726c20e432ae93856b59c58dccb6ef02783cb1263987931401aa9e064bb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 30074182
PQID 2083708803
PQPubID 23479
PageCount 7
ParticipantIDs wanfang_journals_tjykdxxb_e201802007
proquest_miscellaneous_2083708803
pubmed_primary_30074182
crossref_citationtrail_10_1007_s11596_018_1872_7
crossref_primary_10_1007_s11596_018_1872_7
springer_journals_10_1007_s11596_018_1872_7
PublicationCentury 2000
PublicationDate 2018-04-01
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 04
  year: 2018
  text: 2018-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Wuhan
PublicationPlace_xml – name: Wuhan
– name: China
PublicationTitle Current medical science
PublicationTitleAbbrev CURR MED SCI
PublicationTitleAlternate Curr Med Sci
PublicationTitle_FL Journal of Huazhong University of Science and Technology(Medical Science)
PublicationYear 2018
Publisher Huazhong University of Science and Technology
Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430060, China%Department of Emergency Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China%Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
Publisher_xml – name: Huazhong University of Science and Technology
– name: Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China%Department of Medical Ultrasound, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430060, China%Department of Emergency Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China%Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
References Young, Santhanam, Yoshikawa (CR23) 2010; 10
Paoli, Giannoni, Chiarugi (CR1) 2013; 1833
Pfeffer, Yang, Pfeffer (CR10) 2015; 76
Gaudelot, Gibier, Pottier (CR29) 2017; 39
Zhu, Xu (CR13) 2014; 9
He, Dong, Zhai (CR30) 2015; 6
Wu, Yang, Xiang (CR18) 2014; 34
Yang, Zheng, Yan (CR3) 2013; 296
Khalid, Hussain, Manzoor (CR26) 2017; 39
Sicard, Gayral, Lulka (CR32) 2013; 21
Schafer, Grassian, Song (CR15) 2009; 461
Kong, Ferland-McCollough, Jackson (CR7) 2012; 13
Yan, Wu, Zhang (CR31) 2011; 13
Liu, Zhu, Yang (CR9) 2014; 35
Yu, Hu, Kuang (CR17) 2013; 19
Gross, Kropp, Khatib (CR8) 2017; 6
Winther, Alsner, Tramm (CR21) 2015; 54
Markou, Zavridou, Lianidou (CR11) 2016; 7
Kumar, Rajendran, Sethumadhavan (CR27) 2013; 2013
Chen, Xu, Chen (CR28) 2015; 3
Slattum, Rosenblatt (CR5) 2014; 14
Malagobadan, Nagoor (CR2) 2015; 2015
Wang, Wang, Tang (CR24) 2015; 580
Meng, Lu, Mei (CR20) 2014; 47
Esteller (CR6) 2011; 12
Feber, Xi, Luketich (CR19) 2008; 135
Wang, Li, Zhu (CR14) 2014; 14
Zhao, Schnitzler, Iyer (CR12) 2016; 11
Pan, Wang, Wang (CR22) 2010; 10
Ming, He (CR25) 2012; 319
Livak, Schmittgen (CR16) 2001; 25
Pachmayr, Treese, Stein (CR4) 2017; 33
W Zhu (1872_CR13) 2014; 9
G Wang (1872_CR24) 2015; 580
M Esteller (1872_CR6) 2011; 12
W Wang (1872_CR14) 2014; 14
S Malagobadan (1872_CR2) 2015; 2015
J Liu (1872_CR9) 2014; 35
J Yang (1872_CR3) 2013; 296
LX Yan (1872_CR31) 2011; 13
X Pan (1872_CR22) 2010; 10
SR Pfeffer (1872_CR10) 2015; 76
A Khalid (1872_CR26) 2017; 39
F Sicard (1872_CR32) 2013; 21
KJ Livak (1872_CR16) 2001; 25
C He (1872_CR30) 2015; 6
J Zhao (1872_CR12) 2016; 11
A Kumar (1872_CR27) 2013; 2013
MR Young (1872_CR23) 2010; 10
E Pachmayr (1872_CR4) 2017; 33
P Paoli (1872_CR1) 2013; 1833
J Chen (1872_CR28) 2015; 3
MF Wu (1872_CR18) 2014; 34
N Gross (1872_CR8) 2017; 6
A Markou (1872_CR11) 2016; 7
YW Kong (1872_CR7) 2012; 13
XR Meng (1872_CR20) 2014; 47
K Gaudelot (1872_CR29) 2017; 39
GM Slattum (1872_CR5) 2014; 14
ZT Schafer (1872_CR15) 2009; 461
A Feber (1872_CR19) 2008; 135
M Winther (1872_CR21) 2015; 54
M Ming (1872_CR25) 2012; 319
SJ Yu (1872_CR17) 2013; 19
28210157 - Lung Cancer (Auckl). 2016 Mar 02;7:19-27
24943812 - Nat Rev Cancer. 2014 Jul;14(7):495-501
19693011 - Nature. 2009 Sep 3;461(7260):109-13
28906477 - Biology (Basel). 2017 Sep 14;6(3):null
22652233 - Lancet Oncol. 2012 Jun;13(6):e249-58
11846609 - Methods. 2001 Dec;25(4):402-8
24327805 - ScientificWorldJournal. 2013 Nov 13;2013:756134
22094949 - Nat Rev Genet. 2011 Nov 18;12(12):861-74
28714373 - Tumour Biol. 2017 Jul;39(7):1010428317707372
28785563 - Visc Med. 2017 Mar;33(1):11-20
18242245 - J Thorac Cardiovasc Surg. 2008 Feb;135(2):255-60; discussion 260
26587543 - Biomed Res Int. 2015;2015:716816
28621226 - Tumour Biol. 2017 Jun;39(6):1010428317705754
25098614 - Braz J Med Biol Res. 2014 Sep;47(9):811-7
22266095 - Cancer Lett. 2012 Jun 28;319(2):125-129
20368367 - Mol Interv. 2010 Apr;10(2):76-9
26734640 - Ann Transl Med. 2015 Dec;3(21):330
24710931 - J Huazhong Univ Sci Technolog Med Sci. 2014 Apr;34(2):190-194
23340296 - Clin Cancer Res. 2013 Mar 15;19(6):1389-99
23830918 - Biochim Biophys Acta. 2013 Dec;1833(12):3481-3498
24446181 - Tumour Biol. 2014 May;35(5):3975-9
26481465 - Acta Oncol. 2015;54(9):1582-91
25376700 - BMC Cancer. 2014 Nov 07;14:819
27276022 - PLoS One. 2016 Jun 08;11(6):e0156772
23481326 - Mol Ther. 2013 May;21(5):986-94
26311740 - Oncotarget. 2015 Oct 6;6(30):28867-81
21219636 - Breast Cancer Res. 2011 Jan 10;13(1):R2
21139417 - Cancer Biol Ther. 2010 Dec 15;10(12):1224-32
25098165 - PLoS One. 2014 Aug 06;9(8):e103373
26082192 - Drug Dev Res. 2015 Sep;76(6):270-7
26142886 - Arch Biochem Biophys. 2015 Aug 15;580:64-74
23963853 - Anat Rec (Hoboken). 2013 Oct;296(10):1501-8
References_xml – volume: 1833
  start-page: 3481
  issue: 12
  year: 2013
  end-page: 3498
  ident: CR1
  article-title: Anoikis molecular pathways and its role in cancer progression
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbamcr.2013.06.026
– volume: 76
  start-page: 270
  issue: 6
  year: 2015
  end-page: 277
  ident: CR10
  article-title: The Role of miR-21 in Cancer
  publication-title: Drug Dev Res
  doi: 10.1002/ddr.21257
– volume: 6
  start-page: 28867
  issue: 30
  year: 2015
  end-page: 28881
  ident: CR30
  article-title: MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway
  publication-title: Oncotarget
– volume: 2015
  start-page: 716816
  year: 2015
  ident: CR2
  article-title: Evaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic Potential
  publication-title: Biomed Res Int
  doi: 10.1155/2015/716816
– volume: 13
  start-page: e249
  issue: 6
  year: 2012
  end-page: 258
  ident: CR7
  article-title: microRNAs in cancer management
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(12)70073-6
– volume: 580
  start-page: 64
  year: 2015
  end-page: 74
  ident: CR24
  article-title: Targeting strategies on miRNA-21 and PDCD4 for glioblastoma
  publication-title: Arch Biochem Biophys
  doi: 10.1016/j.abb.2015.07.001
– volume: 19
  start-page: 1389
  issue: 6
  year: 2013
  end-page: 1399
  ident: CR17
  article-title: MircroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-12-1959
– volume: 2013
  start-page: 756134
  year: 2013
  ident: CR27
  article-title: AKT kinase pathway: a leading target in cancer research
  publication-title: Sci World J
– volume: 319
  start-page: 125
  issue: 2
  year: 2012
  end-page: 129
  ident: CR25
  article-title: PTEN in DNA damage repair
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2012.01.003
– volume: 135
  start-page: 255
  issue: 2
  year: 2008
  end-page: 260
  ident: CR19
  article-title: MicroRNA expression profiles of esophageal cancer
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2007.08.055
– volume: 21
  start-page: 986
  issue: 5
  year: 2013
  end-page: 994
  ident: CR32
  article-title: Targeting miR-21 for the therapy of pancreatic cancer
  publication-title: Mol Ther
  doi: 10.1038/mt.2013.35
– volume: 461
  start-page: 109
  issue: 7260
  year: 2009
  end-page: 113
  ident: CR15
  article-title: Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
  publication-title: Nature
  doi: 10.1038/nature08268
– volume: 10
  start-page: 1224
  issue: 12
  year: 2010
  end-page: 1232
  ident: CR22
  article-title: MicroRNA-21: a novel therapeutic target in human cancer
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.10.12.14252
– volume: 35
  start-page: 3975
  issue: 5
  year: 2014
  end-page: 3979
  ident: CR9
  article-title: MicroRNA-21 is a novel promising target in cancer radiation therapy
  publication-title: Tumour Biol
  doi: 10.1007/s13277-014-1623-8
– volume: 34
  start-page: 190
  issue: 2
  year: 2014
  end-page: 194
  ident: CR18
  article-title: miR-21 targets Fas ligand-mediated apoptosis in breast cancer cell line MCF-7
  publication-title: J Huazhong Univ Sci Technolog Med Sci
  doi: 10.1007/s11596-014-1257-5
– volume: 7
  start-page: 19
  year: 2016
  end-page: 27
  ident: CR11
  article-title: miRNA-21 as a novel therapeutic target in lung cancer
  publication-title: Lung Cancer (Auckl)
– volume: 10
  start-page: 76
  issue: 2
  year: 2010
  end-page: 79
  ident: CR23
  article-title: Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue
  publication-title: Mol Interv
  doi: 10.1124/mi.10.2.5
– volume: 11
  start-page: e0156772
  issue: 6
  year: 2016
  ident: CR12
  article-title: MicroRNAOffset RNA Alters Gene Expression and Cell Proliferation
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0156772
– volume: 12
  start-page: 861
  issue: 12
  year: 2011
  end-page: 874
  ident: CR6
  article-title: Non-coding RNAs in human disease
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg3074
– volume: 14
  start-page: 819
  year: 2014
  ident: CR14
  article-title: MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-819
– volume: 25
  start-page: 402
  issue: 4
  year: 2001
  end-page: 408
  ident: CR16
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta DeltaC(T)) method
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 33
  start-page: 11
  issue: 1
  year: 2017
  end-page: 20
  ident: CR4
  article-title: Underlying Mechanisms for Distant Metastasis—Molecular Biology
  publication-title: Visc Med
  doi: 10.1159/000454696
– volume: 6
  start-page: 34
  issue: 3
  year: 2017
  ident: CR8
  article-title: MicroRNA Signaling in Embryo Development
  publication-title: Biology (Basel)
– volume: 14
  start-page: 495
  issue: 7
  year: 2014
  end-page: 501
  ident: CR5
  article-title: Tumour cell invasion: an emerging role for basal epithelial cell extrusion
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3767
– volume: 39
  start-page: 1010428317705754
  issue: 6
  year: 2017
  ident: CR26
  article-title: PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma
  publication-title: Tumour Biol
  doi: 10.1177/1010428317705754
– volume: 3
  start-page: 330
  issue: 21
  year: 2015
  ident: CR28
  article-title: The critical roles of miR-21 in anti-cancer effects of curcumin
  publication-title: Ann Transl Med
– volume: 39
  start-page: 1010428317707372
  issue: 7
  year: 2017
  ident: CR29
  article-title: Targeting miR-21 decreases expression of multi-drug resistant genes and promotes chemosensitivity of renal carcinoma
  publication-title: Tumour Biol
  doi: 10.1177/1010428317707372
– volume: 296
  start-page: 1501
  issue: 10
  year: 2013
  end-page: 1508
  ident: CR3
  article-title: Integration of autophagy and anoikis resistance in solid tumors
  publication-title: Anat Rec (Hoboken)
  doi: 10.1002/ar.22769
– volume: 54
  start-page: 1582
  issue: 9
  year: 2015
  end-page: 1591
  ident: CR21
  article-title: Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer
  publication-title: Acta Oncol
  doi: 10.3109/0284186X.2015.1064161
– volume: 47
  start-page: 811
  issue: 9
  year: 2014
  end-page: 817
  ident: CR20
  article-title: Expression analysis of miRNA and target mRNAs in esophageal cancer
  publication-title: Braz J Med Biol Res
  doi: 10.1590/1414-431X20143906
– volume: 9
  start-page: e103373
  issue: 8
  year: 2014
  ident: CR13
  article-title: MicroRNA-21 identified as predictor of cancer outcome: a meta-analysis
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0103373
– volume: 13
  start-page: R2
  issue: 1
  year: 2011
  ident: CR31
  article-title: Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, migration and tumor growth
  publication-title: Breast Cancer Res
  doi: 10.1186/bcr2803
– volume: 3
  start-page: 330
  issue: 21
  year: 2015
  ident: 1872_CR28
  publication-title: Ann Transl Med
– volume: 13
  start-page: R2
  issue: 1
  year: 2011
  ident: 1872_CR31
  publication-title: Breast Cancer Res
  doi: 10.1186/bcr2803
– volume: 14
  start-page: 495
  issue: 7
  year: 2014
  ident: 1872_CR5
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3767
– volume: 13
  start-page: e249
  issue: 6
  year: 2012
  ident: 1872_CR7
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(12)70073-6
– volume: 135
  start-page: 255
  issue: 2
  year: 2008
  ident: 1872_CR19
  publication-title: J Thorac Cardiovasc Surg
  doi: 10.1016/j.jtcvs.2007.08.055
– volume: 1833
  start-page: 3481
  issue: 12
  year: 2013
  ident: 1872_CR1
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbamcr.2013.06.026
– volume: 296
  start-page: 1501
  issue: 10
  year: 2013
  ident: 1872_CR3
  publication-title: Anat Rec (Hoboken)
  doi: 10.1002/ar.22769
– volume: 12
  start-page: 861
  issue: 12
  year: 2011
  ident: 1872_CR6
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg3074
– volume: 6
  start-page: 34
  issue: 3
  year: 2017
  ident: 1872_CR8
  publication-title: Biology (Basel)
– volume: 19
  start-page: 1389
  issue: 6
  year: 2013
  ident: 1872_CR17
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-12-1959
– volume: 6
  start-page: 28867
  issue: 30
  year: 2015
  ident: 1872_CR30
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.4814
– volume: 2015
  start-page: 716816
  year: 2015
  ident: 1872_CR2
  publication-title: Biomed Res Int
  doi: 10.1155/2015/716816
– volume: 10
  start-page: 76
  issue: 2
  year: 2010
  ident: 1872_CR23
  publication-title: Mol Interv
  doi: 10.1124/mi.10.2.5
– volume: 7
  start-page: 19
  year: 2016
  ident: 1872_CR11
  publication-title: Lung Cancer (Auckl)
– volume: 25
  start-page: 402
  issue: 4
  year: 2001
  ident: 1872_CR16
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 39
  start-page: 101042831770737
  issue: 7
  year: 2017
  ident: 1872_CR29
  publication-title: Tumour Biol
  doi: 10.1177/1010428317707372
– volume: 33
  start-page: 11
  issue: 1
  year: 2017
  ident: 1872_CR4
  publication-title: Visc Med
  doi: 10.1159/000454696
– volume: 76
  start-page: 270
  issue: 6
  year: 2015
  ident: 1872_CR10
  publication-title: Drug Dev Res
  doi: 10.1002/ddr.21257
– volume: 10
  start-page: 1224
  issue: 12
  year: 2010
  ident: 1872_CR22
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.10.12.14252
– volume: 54
  start-page: 1582
  issue: 9
  year: 2015
  ident: 1872_CR21
  publication-title: Acta Oncol
  doi: 10.3109/0284186X.2015.1064161
– volume: 14
  start-page: 819
  year: 2014
  ident: 1872_CR14
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-14-819
– volume: 580
  start-page: 64
  year: 2015
  ident: 1872_CR24
  publication-title: Arch Biochem Biophys
  doi: 10.1016/j.abb.2015.07.001
– volume: 35
  start-page: 3975
  issue: 5
  year: 2014
  ident: 1872_CR9
  publication-title: Tumour Biol
  doi: 10.1007/s13277-014-1623-8
– volume: 39
  start-page: 101042831770575
  issue: 6
  year: 2017
  ident: 1872_CR26
  publication-title: Tumour Biol
  doi: 10.1177/1010428317705754
– volume: 11
  start-page: e0156772
  issue: 6
  year: 2016
  ident: 1872_CR12
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0156772
– volume: 319
  start-page: 125
  issue: 2
  year: 2012
  ident: 1872_CR25
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2012.01.003
– volume: 461
  start-page: 109
  issue: 7260
  year: 2009
  ident: 1872_CR15
  publication-title: Nature
  doi: 10.1038/nature08268
– volume: 9
  start-page: e103373
  issue: 8
  year: 2014
  ident: 1872_CR13
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0103373
– volume: 34
  start-page: 190
  issue: 2
  year: 2014
  ident: 1872_CR18
  publication-title: J Huazhong Univ Sci Technolog Med Sci
  doi: 10.1007/s11596-014-1257-5
– volume: 2013
  start-page: 756134
  year: 2013
  ident: 1872_CR27
  publication-title: Sci World J
  doi: 10.1155/2013/756134
– volume: 47
  start-page: 811
  issue: 9
  year: 2014
  ident: 1872_CR20
  publication-title: Braz J Med Biol Res
  doi: 10.1590/1414-431X20143906
– volume: 21
  start-page: 986
  issue: 5
  year: 2013
  ident: 1872_CR32
  publication-title: Mol Ther
  doi: 10.1038/mt.2013.35
– reference: 22094949 - Nat Rev Genet. 2011 Nov 18;12(12):861-74
– reference: 26082192 - Drug Dev Res. 2015 Sep;76(6):270-7
– reference: 22266095 - Cancer Lett. 2012 Jun 28;319(2):125-129
– reference: 25376700 - BMC Cancer. 2014 Nov 07;14:819
– reference: 20368367 - Mol Interv. 2010 Apr;10(2):76-9
– reference: 23963853 - Anat Rec (Hoboken). 2013 Oct;296(10):1501-8
– reference: 23830918 - Biochim Biophys Acta. 2013 Dec;1833(12):3481-3498
– reference: 28906477 - Biology (Basel). 2017 Sep 14;6(3):null
– reference: 24710931 - J Huazhong Univ Sci Technolog Med Sci. 2014 Apr;34(2):190-194
– reference: 26311740 - Oncotarget. 2015 Oct 6;6(30):28867-81
– reference: 24943812 - Nat Rev Cancer. 2014 Jul;14(7):495-501
– reference: 11846609 - Methods. 2001 Dec;25(4):402-8
– reference: 24327805 - ScientificWorldJournal. 2013 Nov 13;2013:756134
– reference: 23340296 - Clin Cancer Res. 2013 Mar 15;19(6):1389-99
– reference: 26142886 - Arch Biochem Biophys. 2015 Aug 15;580:64-74
– reference: 19693011 - Nature. 2009 Sep 3;461(7260):109-13
– reference: 25098614 - Braz J Med Biol Res. 2014 Sep;47(9):811-7
– reference: 28785563 - Visc Med. 2017 Mar;33(1):11-20
– reference: 21139417 - Cancer Biol Ther. 2010 Dec 15;10(12):1224-32
– reference: 28210157 - Lung Cancer (Auckl). 2016 Mar 02;7:19-27
– reference: 26587543 - Biomed Res Int. 2015;2015:716816
– reference: 22652233 - Lancet Oncol. 2012 Jun;13(6):e249-58
– reference: 18242245 - J Thorac Cardiovasc Surg. 2008 Feb;135(2):255-60; discussion 260
– reference: 26481465 - Acta Oncol. 2015;54(9):1582-91
– reference: 27276022 - PLoS One. 2016 Jun 08;11(6):e0156772
– reference: 25098165 - PLoS One. 2014 Aug 06;9(8):e103373
– reference: 28621226 - Tumour Biol. 2017 Jun;39(6):1010428317705754
– reference: 23481326 - Mol Ther. 2013 May;21(5):986-94
– reference: 24446181 - Tumour Biol. 2014 May;35(5):3975-9
– reference: 26734640 - Ann Transl Med. 2015 Dec;3(21):330
– reference: 28714373 - Tumour Biol. 2017 Jul;39(7):1010428317707372
– reference: 21219636 - Breast Cancer Res. 2011 Jan 10;13(1):R2
SSID ssib031263182
ssj0002039635
ssib051367596
ssib034325102
ssj0057624
Score 2.2555027
Snippet Summary Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis...
Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix. It has been determined that acquisition of resistance to anoikis is a...
Anoikis is a form of apoptosis induced upon cell detachment from extracellular matrix.It has been determined that acquisition of resistance to anoikis is a...
SourceID wanfang
proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 245
SubjectTerms Medicine
Medicine & Public Health
Title MiR-21 Suppresses Anoikis through Targeting PDCD4 and PTEN in Human Esophageal Adenocarcinoma
URI https://link.springer.com/article/10.1007/s11596-018-1872-7
https://www.ncbi.nlm.nih.gov/pubmed/30074182
https://www.proquest.com/docview/2083708803
https://d.wanfangdata.com.cn/periodical/tjykdxxb-e201802007
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3rS8MwEA8-QPwivp0vIuyTUuiSpms_Dp2IMBHZYF8kJG0qm5rJuoH-99616TZRBn7Pg17u2bv7HSF17mvdjEQGkhYoL4iyphdrhSiiiQoQKFYp7B3uPIR3veC-L_qujzuvqt2rlGShqefNbmB5MfqFg6ImuIWrZF1A6I51XD3WqpiIN1gIfDqz2dg4KRYwsgRilAmHMTcsM3HAhFjqyMCdx8Bslv3869af9uuXU7qQUC3agGym7MuCxbrdJlvO1aStkjd2yIqxu2Sj45Lpe-S5M3jyWIPiYM8CQjynLTsagEdJ3fQe2i3qxOEe-nhzfRNQZVP62G0_0IGlxe9_2sYxCKCT8CJQYWAZx3D66F3tk95tu3t957lpC17CI3_i6YafwheGCfMN0EyZmEci1CJORJQmiQ5NhllKnmikcByBYGNwplRswK3Rmh-QNTuy5ohQ0AFpBkaPcwXRXUOo0KSpYjoF5wt7b2vEr2goEwdFjhMx3uQcRBnJLoHsEskuYcvlbMtHicOxbPFF9TASpAVTIMqa0TSXzEewH9BZvEYOyxebHccL9ypiNXJVPaF0Ap0vu6vuXnm-eDL8ek0_P7U0DPHR8Hfw8b8OPSGbuLOsEDola5Px1JyB8zPR5wWzfwP-__Dr
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBddBm1fxj7aNfvoNMhTi8GRLEd-DPkg7ZpQRgJ5KUKy5ZFuVUqTQvrf986Wk4yOwN6lEz6d7n7y6X5HSIOHxrSkyOGkRTqIZN4KEqORRTTVERLFao21w8NRPJhEl1Mx9XXci-q1e5WSLDz1ptgNIi_efkGQbAEsfEVeAxaQaMoT1q6MiDdZDHa6jtlYOCm2OLIEcpQJzzF3W2biwAjxqSMDOI8Xs3X281-r_h2_XoDSrYRqUQbkcu1-bUWs_lvyxkNN2i5t4x3Zs-492R_6ZPoHcjOc_QxYk2Jjz4JCfEHbbj4DREl99x46Lt6Jwzr0utvpRlS7jF6PeyM6c7T4_U972AYBfBIuBC4MIuMDSJ_f6SMy6ffGnUHguy0EKZfhMjDNMIMvjFMWWtCZtgmXIjYiSYXM0tTENscsJU8NajiRcLDxcqZ1YgHWGMOPSc3NnT0hFHxAlkPQ41zD7a4pdGyzTDOTAfjC2ts6CSsdqtRTkWNHjD9qQ6KMalegdoVqVzDlbD3lvuTh2DX4e7UxCk4LpkC0s_PHhWIhkv2Az-J18rHcsbU4XsAryerkvNpC5Q_0YtdaDb_Lm8HL26ff2WpllGXIj4a_gz_9l9Bv5GAwHl6pq4vRj8_kEKWUr4W-kNry4dF-BSC0NKeF4T8Dh4Hz3g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1RT9swELYGkxAvE7AB3QYYiaehiNSO0-Sxoq1go1U1tRIvyLJjBxWYi2iQ4N_vLnHaIhAS7_ZZOZ99n3N33xFyxEOtW4nI4aRFKoiSvBWkWiGLaKYiJIpVCmuH-4P4bBz9vhSXvs_prM52r0OSVU0DsjS54uTe5CeLwjfwwvgSBqFJCyDiCvkcYTEwGPSYtWuD4k0Wg83O_TcWUYolviyBfGXC883dVFE5MEhMe2QA7fGRNo-EvrXqS1_2CqAuBVfLkiCXK3e95L16G-SLh520XdnJJvlk3RZZ6_vA-ldy1Z_8DViTYpPPkk58RttuOgF0SX0nHzoqc8ZhHTrsnHYiqpyhw1F3QCeOlqEA2sWWCHA_4UJwnYGXfADp03_qGxn3uqPTs8B3XggynoRFoJuhgS-MMxZa0JmyKU9ErEWaicRkmY5tjhFLnmnUcJrAIceHmlKpBYijNd8mq27q7C6hcB-YHBwg5wpeek2hYmuMYtoAEMM63AYJax3KzNOSY3eMO7kgVEa1S1C7RLVLmPJrPuW-4uR4b_BhvTESTg6GQ5Sz08eZZCES_8D9xRtkp9qxuTheQq2ENchxvYXSH-7Ze2sd-V1eDC5unm_N05OWliFXGv4a_v4hoQdkbdjpyYvzwZ8fZB2FVIlDP8lq8fBo9wATFXq_tPv_-GP4EQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MiR-21+Suppresses+Anoikis+through+Targeting+PDCD4+and+PTEN+in+Human+Esophageal+Adenocarcinoma&rft.jtitle=Current+medical+science&rft.au=Zhao%2C+Meng-ya&rft.au=Wang%2C+La-mei&rft.au=Liu%2C+Jing&rft.au=Huang%2C+Xing&rft.date=2018-04-01&rft.pub=Huazhong+University+of+Science+and+Technology&rft.issn=2096-5230&rft.eissn=2523-899X&rft.volume=38&rft.issue=2&rft.spage=245&rft.epage=251&rft_id=info:doi/10.1007%2Fs11596-018-1872-7&rft.externalDocID=10_1007_s11596_018_1872_7
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg